Literature DB >> 23398155

Regulation and repair of the alveolar-capillary barrier in acute lung injury.

Jahar Bhattacharya1, Michael A Matthay.   

Abstract

Considerable progress has been made in understanding the basic mechanisms that regulate fluid and protein exchange across the endothelial and epithelial barriers of the lung under both normal and pathological conditions. Clinically relevant lung injury occurs most commonly from severe viral and bacterial infections, aspiration syndromes, and severe shock. The mechanisms of lung injury have been identified in both experimental and clinical studies. Recovery from lung injury requires the reestablishment of an intact endothelial barrier and a functional alveolar epithelial barrier capable of secreting surfactant and removing alveolar edema fluid. Repair mechanisms include the participation of endogenous progenitor cells in strategically located niches in the lung. Novel treatment strategies include the possibility of cell-based therapy that may reduce the severity of lung injury and enhance lung repair.

Entities:  

Mesh:

Year:  2013        PMID: 23398155     DOI: 10.1146/annurev-physiol-030212-183756

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  105 in total

1.  Reactive Oxygen Species/Hypoxia-Inducible Factor-1α/Platelet-Derived Growth Factor-BB Autocrine Loop Contributes to Cocaine-Mediated Alveolar Epithelial Barrier Damage.

Authors:  Lu Yang; Xufeng Chen; Samantha M Simet; Guoku Hu; Yu Cai; Fang Niu; Yeonhee Kook; Shilpa J Buch
Journal:  Am J Respir Cell Mol Biol       Date:  2016-11       Impact factor: 6.914

Review 2.  Lung Repair and Regeneration in ARDS: Role of PECAM1 and Wnt Signaling.

Authors:  Jesús Villar; Haibo Zhang; Arthur S Slutsky
Journal:  Chest       Date:  2018-10-28       Impact factor: 9.410

3.  Direct factor Xa inhibition attenuates acute lung injury progression via modulation of the PAR-2/NF-κB signaling pathway.

Authors:  Meng Shi; Linlin Wang; Jian Zhou; Shimeng Ji; Ningfang Wang; Lin Tong; Jing Bi; Yuanlin Song; Jie Hu; Xiaofeng Chen
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

4.  Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin.

Authors:  Robert D Guzy; Ivan Stoilov; Timothy J Elton; Robert P Mecham; David M Ornitz
Journal:  Am J Respir Cell Mol Biol       Date:  2015-01       Impact factor: 6.914

Review 5.  The lung communication network.

Authors:  Davide Losa; Marc Chanson
Journal:  Cell Mol Life Sci       Date:  2015-06-23       Impact factor: 9.261

Review 6.  Ubiquitin-proteasome signaling in lung injury.

Authors:  Natalia D Magnani; Laura A Dada; Jacob I Sznajder
Journal:  Transl Res       Date:  2018-04-23       Impact factor: 7.012

7.  Endothelial barrier protection by local anesthetics: ropivacaine and lidocaine block tumor necrosis factor-α-induced endothelial cell Src activation.

Authors:  Tobias Piegeler; E Gina Votta-Velis; Farnaz R Bakhshi; Mao Mao; Graeme Carnegie; Marcelo G Bonini; David E Schwartz; Alain Borgeat; Beatrice Beck-Schimmer; Richard D Minshall
Journal:  Anesthesiology       Date:  2014-06       Impact factor: 7.892

Review 8.  Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Elizabeth A Middleton; Matthew T Rondina; Hansjorg Schwertz; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

9.  Critical role of autophagy regulator Beclin1 in endothelial cell inflammation and barrier disruption.

Authors:  Antony Leonard; Michelle Warren Millar; Spencer A Slavin; Kaiser M Bijli; Dawling A Dionisio Santos; David A Dean; Fabeha Fazal; Arshad Rahman
Journal:  Cell Signal       Date:  2019-05-01       Impact factor: 4.315

10.  Effect of cefoperazone sulbactam sodium combined with meropenem on the immune function in the treatment of neonatal pneumonia caused by multidrug-resistant bacteria.

Authors:  Mingjing Lin; Shuxia Zhu; Haimei Weng; Yi Zhu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.